Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Allison Izsak"'
Autor:
Brandilyn A. Peters, Melissa Wilson, Una Moran, Anna Pavlick, Allison Izsak, Todd Wechter, Jeffrey S. Weber, Iman Osman, Jiyoung Ahn
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-14 (2019)
Abstract Background Recent evidence suggests that immunotherapy efficacy in melanoma is modulated by gut microbiota. Few studies have examined this phenomenon in humans, and none have incorporated metatranscriptomics, important for determining expres
Externí odkaz:
https://doaj.org/article/6c3d4a5a7b3147f19474d1c8912c2453
Autor:
Iman Osman, Anna C. Pavlick, Melissa Wilson, Brandilyn A. Peters, Allison Izsak, Una Moran, Jiyoung Ahn, Jeffrey S. Weber, Todd Wechter
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-14 (2019)
Genome Medicine
Genome Medicine
Background Recent evidence suggests that immunotherapy efficacy in melanoma is modulated by gut microbiota. Few studies have examined this phenomenon in humans, and none have incorporated metatranscriptomics, important for determining expression of m
Autor:
Irineu Illa Bochaca, Allison Izsak, Alexander C. Jordan, Amel Salhi, Iman Osman, Yariv Houvras, Keith M. Giles, Farbod Darvishian
Publikováno v:
Am J Pathol
Dermal invasion is a hallmark of malignant melanoma. Although the molecular alterations that drive the progression of primary melanoma to metastatic disease have been studied extensively, the early progression of noninvasive primary melanoma to an in
Autor:
Eleazar Vega-Saenz de Miera, Keith M. Giles, Irineu Illa Bochaca, Allison Izsak, Jinhua Wang, Brooke E Rosenbaum, Farbod Darvishian, Marlies Berger, Hua Zhong, Iman Osman, Yang Li
Publikováno v:
The Journal of investigative dermatology. 139(2)
The extent of PTEN loss that confers clinical and biological impact in melanoma is unclear. We evaluated the clinical and biologic relevance of PTEN dosage in melanoma and tested the postulate that partial PTEN loss is due to epigenetic mechanisms. P
Autor:
Mei-Ju May Chen, Susan J Brown, Victoria Guzman, Prashant S. Hosmani, Helen Wiersma-Koch, Sherry Miller, Surya Saha, Kyle Buller, Christopher P. Childers, Haobo Jiang, David R. Nelson, Mirella Flores, Liliana M. Cano, Andrew J. Rosendale, Allison Izsak, Lukas A Mueller, Chris Cordola, Joshua Von Voorhis, Robert G. Shatters, Daniel DeAvila, Adam C. English, Samantha Nandyal, Gabe DeAvila, Kathryn Ciolkevich, Wayne B. Hunter, Xiaolong Cao, Shannon L. Johnson, Zachary W. Q. Moore, Nan Leng, Brandi L. Cantarel, Hannah Mann, Tom D’Elia, David Hunter, Andrew G. Cridge, Tracey Bell, Danielle E. Dixon, Megan E. Dunlevy, Monica F. Poelchau, Taylar Morgan, Joshua B. Benoit, Teresa D. Shippy, Kayla Shore, Robert Mahoney, Krystal Villalobos-Ayala, Monica Munoz-Torres, Stephen Richards, Michelle Cilia, David W. Farrow
Publikováno v:
Database: The Journal of Biological Databases and Curation
The Asian citrus psyllid (Diaphorina citri Kuwayama) is the insect vector of the bacterium Candidatus Liberibacter asiaticus (CLas), the pathogen associated with citrus Huanglongbing (HLB, citrus greening). HLB threatens citrus production worldwide.
Autor:
Robert Ferguson, Anna C. Pavlick, Yesung Lee, Tomas Kirchhoff, Allison Izsak, Iman Osman, Danny Simpson, Richard L. Shapiro, Melissa Wilson, Esther Kazlow, Una Moran, T. Hekal
Publikováno v:
Annals of Oncology. 29:viii463
Autor:
Allison Izsak, Brandilyn A. Peters, Jiyoung Ahn, Anna C. Pavlick, Jeffrey S. Weber, Todd Wechter, Iman Osman, Melissa Wilson, Una Moran
Publikováno v:
Journal of Clinical Oncology. 36:9575-9575
9575Background: Treatment of melanoma with checkpoint blockade immunotherapy brings potential for long-term freedom from progression. However, responses to immunotherapy are heterogeneous, and impr...
Autor:
Eleazar Vega-Saenz de Miera, Anna C. Pavlick, Russell S. Berman, Una Moran, Jennifer A. Stein, Kevin P. Lui, Richard L. Shapiro, Farbod Darvishian, Allison Izsak, Iman Osman, Melissa Wilson, Ann Y. Lee, Keith M. Giles, Sarah A. Weiss
Publikováno v:
Journal of Clinical Oncology. 35:9534-9534
9534 Background: Efforts to identify targeted therapies that can improve treatment outcome in metastatic ALM have been unsuccessful. In a previous genomic screening, we identified copy number amplification of the histone methyltransferase EZH2 in 47%